Fortis Healthcare is currently trading at Rs. 303.65, up by 0.75 points or 0.25% from its previous closing of Rs. 302.90 on the BSE.
The scrip opened at Rs. 304.85 and has touched a high and low of Rs. 309.70 and Rs. 303.30 respectively. So far 38174 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 324.80 on 19-Sep-2022 and a 52 week low of Rs. 228.65 on 29-Jun-2022.
Last one week high and low of the scrip stood at Rs. 311.95 and Rs. 298.65 respectively. The current market cap of the company is Rs. 23030.00 crore.
The promoters holding in the company stood at 31.17%, while Institutions and Non-Institutions held 51.91% and 16.92% respectively.
Fortis Healthcare has tied up with emergency response network RED.Health to offer end-to-end emergency services. The collaboration is driven by a shared vision to provide end-to-end emergency services within the minimum response time and reduce trauma and fatalities during medical emergencies.
The scope of the collaboration spans across seven branches of Fortis Hospitals in Delhi/NCR. As part of the collaboration, RED.Health will deploy 10 dedicated GPS-enabled advanced life support (ALS) ambulances and also support patient logistics with an independent fleet of over 30 vehicles in NCR, ensuring that ambulances reach patients within around 10 to 30 minutes.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning various countries.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7743.95 |
| Max Healthcare Inst | 1021.50 |
| Narayana Hrudayalay | 1803.60 |
| Aster DM Healthcare | 680.35 |
| Global Health | 1082.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: